RE:RE:Schedule 13d, 13g..and Canadian regulators equivalent..It appears possible another Corp could hold a large stake in Medipharm labs .......it's MediPharm's discretion to share with investors....(at least I can't find any information to the contrary)...typically a company would want to share, highlighting the confidence given...but not in the top secret world of pharmaceutical development...it's interesting 3.6 m from the bought deal was used to increase pharmaceutical API production capabilities...(march 2021)...I'm trying to rule out the possibility that someone like Apotex, or Purdue/Knoa/(NOAT) could have participated in the 2021 bought deal..but I can't rule this out.....there is no found regulation requiring a public company to divulge ownership outside of persons working for the issuer (MediPharm) in this case.....It's in a global pharmaceutical partners interest to own a significant stake for obvious reasons...this company is a highly probable buyout candidate and it's hard to believe MPL is a sitting duck without high ownership of individuals and groups who know it's actual value.